Diabetes does not influence oral oncogenesis through fibroblast growth factor receptors

In Vivo. 2007 Jul-Aug;21(4):623-8.

Abstract

Background: Increased expression of fibroblast growth factors and their receptors (FGFRs) has recently been described in oral squamous cell carcinoma. In addition, we have previously described a molecular basis for an association between oral cancer and diabetes. The expression of FGFR-2 and FGFR-3 investigated in an experimental model of chemically induced carcinogenesis in normal and diabetic (type I) rats.

Materials and methods: Tissue sections ranging from normal mucosa to moderately-differentiated oral squamous cell carcinoma were studied using monoclonal antibodies against FGFR-2 and FGFR-3 proteins.

Results: A similar pattern of elevated FGFR-2 and FGFR-3 expression was observed in the initial stages of oncogenesis for both diabetic and non-diabetic animals. In the last stages of oral oncogenesis, the expression of both proteins remained relatively stable.

Conclusion: It seems that diabetes does not affect the FGFR-2 and FGFR-3 pattern of expression throughout the various stages of oral oncogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal
  • Carcinoma, Squamous Cell / metabolism*
  • Carcinoma, Squamous Cell / pathology
  • Diabetes Mellitus, Type 1 / metabolism*
  • Disease Models, Animal
  • Female
  • Immunohistochemistry
  • Mouth Mucosa / metabolism
  • Mouth Mucosa / pathology
  • Mouth Neoplasms / metabolism*
  • Mouth Neoplasms / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Receptor, Fibroblast Growth Factor, Type 2 / immunology
  • Receptor, Fibroblast Growth Factor, Type 2 / metabolism*
  • Receptor, Fibroblast Growth Factor, Type 3 / immunology
  • Receptor, Fibroblast Growth Factor, Type 3 / metabolism*

Substances

  • Antibodies, Monoclonal
  • Fgfr3 protein, rat
  • Fgfr2 protein, rat
  • Receptor, Fibroblast Growth Factor, Type 2
  • Receptor, Fibroblast Growth Factor, Type 3